•
5 Predictions for Artificial Intelligence in 2020
Talks about AI, 2020 and Technology
RN
Ronjon Nag
Founder of AGEMICA
Palo Alto, California
Overview
Ronjon Nag is the Founder and President of R42 Group, a seasoned entrepreneur and inventor with a diverse background in mobile technology, start-ups, and global business development. He currently serves as an Adjunct Professor at Stanford University School of Medicine, contributing to the fields of genetics and interdisciplinary studies.
Notable highlights of his career include founding R42 Group and serving as an Adjunct Professor at Stanford University School of Medicine, showcasing his expertise in mobile technology and entrepreneurship while also making impactful investments in various companies, such as Concr and Celeris Therapeutics.
Work Experience
Advisor, Stanford Lifestyle Medicine Group
2025 - Current
Adjunct Professor in Genetics in the School of Medicine
2022
Courses taught at Stanford: GENE 213: AI, Genes and Ethics GENE 223: Aging: Longevity Science and Technology GENE 225: Healthcare Venture Capital GENE 226: Longevity Venture Capital GENE 229: How we age SCI 52: Artificial Intelligence: Deep Learning, Human Centered AI and Beyond SCI 53: Artificial Intelligence and Science Fiction: What Sci-Fi Films and TV Shows Can Tell Us About Our Future World SCI 54: Artificial Intelligence Masterclass: Guided Journeys into the Brave New World of AI SCI 57: Artificial Intelligence for Healthcare and Longevity WSP 152/ TECH 152: A Crash Course in Artificial Intelligence BUS 104: Investing in the 2020s: stocks bonds, venture capital and crypto GENE 231: AI for Beginners
Stanford Distinguished Careers Institute Interdisciplinary Fellow
2015
Visiting Fellow, Stanford Center for the Study of Language and Information
2018
Part of the Stanford Boundaries of Humanity project looking at intelligence in humans, animals and machines. boundariesofhumanity.stanford.edu
Director
2025
Director of capAI, using AI to build AI
Founder and President
2019
• R42 Group is a family office and venture group which invests primarily in AI, biotechnology and science, wireless communication technologies. • Work with pre-seed stage companies, helping them navigate through the growth stage.
CEO and Co-founder
2024
Ikshana is developing novel therapies for aging eye disease, including Age-Related Macular Degeneration
Director
2015
MIT Alumni Angels of Northern California is a group of bay area MIT Alumni evaluating investments in deep technology and science companies. Also on Board of Directors of MIT Club of Northern California
Advisor
2015
SkyDeck accelerates technology, science, and disruptive business startups. Our startups have direct access to the massive resources of the UC Berkeley ecosystem.
Co-Founder
2021
Superbio.ai is a software-based data science and machine learning agency.
Chief Executive Officer and Co-founder
2023
Developing a vaccine for aging using AI
Chairman Of The Board
2020
Executive Director
2019
GTCardio creates continuous blood pressure measurement wearables
Education
S.M
1989 - 1991
Harkness Fellow
1991 - 1992
PhD
1984 - 1988
B.Sc. (1st class Hons)
1981 - 1984